Pa. maker of placenta-derived tissue graft obtains $2.23M

02/12/2013 | MedCityNews.com

AFcell Medical has obtained $2.23 million of a targeted $10 million round, which it will use for its sales and marketing team. The Pennsylvania-based startup is the maker of AmnioClear, a tissue graft derived from the placenta of living human donors that could speed recovery for tendon surgery or wound repair patients.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY